A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Odense University Hospital. Recruitment status was Not yet recruiting
Study NCT01042028
Information provided by Odense University Hospital
First Received on January 4, 2010.
Last Updated on January 5, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
